Loading asset research
vTv Therapeutics Inc. Class A Common Stock
VTVTNasdaq · USD · StocksQuote as of · Exchange session not verified$31.97
+0.35%
Today
VTVT
Loading 1D prices…
Market cap
$126.4M
Volume
13.7K
52w high
$44.0052w low
$18.97Company profile
vTv Therapeutics Inc. Class A Common Stock
vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes. The company is also investing a range of molecules across various indications for chronic diseases. It has a license agreement Newsoara Biopharma Co., Ltd. to develop and commercialize phosphodiesterase type 4 inhibitors program. vTv Therapeutics Inc. was incorporated in 2015 and is headquartered in High Point, North Carolina.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
High Point, NC, United States
Employees
26
Fiscal year end
1231
CIK
1641489
Session & valuation
Open$32.24
Previous close$31.86
Day high$32.54
Day low$31.29
30-day avg. volume70.1K
Outstanding shares—
Diluted EPS-$3.20
Latest annual period
P/E (trailing)-9.99
P/E (forward)-7.45
Price / book5.05
Beta0.28
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| BMEABiomea Fusion Inc. Common Stock | $125.8M | $0.00 | — | -$1.18 | +2.35% | Buy |
| OKUROnKure Therapeutics Inc. Class A Common Stock | $125.5M | $0.00 | — | -$4.40 | -5.20% | Buy |
| KZIAKazia Therapeutics Limited American Depositary Shares | $127.9M | — | — | -$18.90 | +1.63% | Buy |
| CNTBConnect Biopharma Holdings Limited Ordinary Shares | $128.5M | $64K | -86687.50% | -$1.00 | -0.97% | Buy |
| INOInovio Pharmaceuticals Inc. Common Stock | $129.2M | $65.3K | -130082.79% | -$1.81 | -2.73% | Buy |